Concepedia

L. Björk

LB

Statistics

Publications

4

Citations

207

H-Index

4

Active since

1991

Affiliations

Lund University(Current)

L. Björk is an author at Lund University specializing in medicine, pharmacology, and behavioral pharmacology.

Publications per year

1991–2004

4

Publications

4

Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.

L. Björk, Linda J. Cornfield, David L. Nelson et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 103 citations

Medicine, Neuroscience, Pharmacology +15

Characteristics, clinical effect profile and tolerability of a nasal spray preparation of Artemisia abrotanum L. for allergic rhinitis

P. Remberg, L. Björk, Thomas Hedner et al. · Phytomedicine · 2004 · 56 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II interleukin-1 receptor cDNA.

Jesper Bristulf, S. Gatti, David Malinowsky et al. · PubMed · 1994 · 38 citations

Life Sciences, Endocrinology, Molecular Biology +14

Doxapram improves pulmonary function after upper abdominal surgery

L. Björk, M Arborelius, H. Renck et al. · Acta Anaesthesiologica Scandinavica · 1993 · 10 citations

Medicine, Anesthesiology, Surgery +13

1–4 of 4